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Streptococcus (S.) suis is one of the most important pathogens in pigs causing meningitis, arthritis, endocarditis and
serositis. Furthermore, it is also an emerging zoonotic agent. In our previous work we identified a highly specific IgM
protease in S. suis, designated IdeSsuis. The objective of this study was to characterize the function of IdeSsuis in the
host-pathogen interaction. Edman-sequencing revealed that IdeSsuis cleaves the heavy chain of the IgM molecule
between constant domain 2 and 3. As the C1q binding motif is located in the C3 domain, we hypothesized that
IdeSsuis is involved in complement evasion. Complement-mediated hemolysis induced by porcine hyperimmune sera
containing erythrocyte-specific IgM was abrogated by treatment of these sera with recombinant IdeSsuis. Furthermore,
expression of IdeSsuis reduced IgM-triggered complement deposition on the bacterial surface. An infection experiment
of prime-vaccinated growing piglets suggested attenuation in the virulence of the mutant 10ΔideSsuis. Bactericidal
assays confirmed a positive effect of IdeSsuis expression on bacterial survival in porcine blood in the presence of high
titers of specific IgM. In conclusion, this study demonstrates that IdeSsuis is a novel complement evasion factor, which
is important for bacterial survival in porcine blood during the early adaptive (IgM-dominated) immune response.Introduction
Streptococcus (S.) suis colonizes different mucosa of pigs,
its main host. Virulent strains might, however, cross the
mucosal barrier, cause bacteremia and infect various
tissues leading to severe pathologies, such as meningitis,
arthritis, endocarditis and serositis. Suppurative meningitis
caused by S. suis is one of the most important diseases in
modern swine production as it is associated with severe
economic losses. S. suis exhibits a high degree of diversity
among and within different serotypes. Serotype 2 is
worldwide the most important serotype isolated from
affected tissues in piglets and also an important zoonotic
agent [1-3].
Numerous proteins involved in interaction with the host
have been functionally characterized [4,5]. Recently, we
identified a 124 kDa large Immunoglobulin M-degrading
enzyme of S. suis, designated IdeSsuis [6]. The N-terminal* Correspondence: christoph.baums@vetmed.uni-leipzig.de
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unless otherwise stated.region of IdeSsuis is homologous to the 38 kDa IgG specific
endoprotease IdeS (also known as Mac-1) expressed by S.
pyogenes and sufficient for IgM cleavage. IdeSsuis is a highly
specific IgM protease expressed by all investigated S. suis
strains, which included strains from four different
serotypes and clonal complexes. Importantly, it is so
far the only known protease cleaving specifically the
intact IgM multimer. The specificity of this protease
is underscored by several findings: (i) IdeSsuis does not
degrade porcine or human IgG or IgA, (ii) IgM of
pigs but not IgM of any other investigated species is
cleaved and (iii) incubation of different body liquids
with IdeSsuis, including cerebrospinal and joint fluids
from diseased piglets, generated only one additional
band in SDS-PAGE in accordance with a specific IgM
cleavage product [6].
Complement activation leads to formation of C3
convertases (C3Bb or C4b2a) cleaving C3 into the
anaphylatoxin C3a and the most important opsonin
C3b. In an experimental mouse model the complement
system proved to be crucial for protection againsthis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tion, as recently demonstrated by our group using C3−/−
mice [7]. Thus, evasion of complement activation is essen-
tial for the survival of S. suis in its host and several factors
involved in complement evasion have been identified in S.
suis. Sialic acid moieties of the capsule of serotype 2 strains
[8] might interfere with the activation of the alternative
complement cascade by increasing the affinity constant of
C3b to the complement inhibitor factor H [9,10]. Ac-
cordingly, deposition of C3b is increased on the bac-
terial surface of an unencapsulated mutant [7].
Furthermore, two factor H binding proteins (Fhb and
SSU0186) both homologous to PspC (Pneumococcal sur-
face protein C) of S. pneumoniae have been identified in S.
suis [11,12]. FhB was shown to contribute to virulence in
experimental infections of piglets and to survival in human
blood ex vivo.
The classical complement pathway is activated by
immunoglobulins, in particular IgM, and some other
host proteins, e. g. choline-binding protein, recognizing
bacterial surface structures [13]. Binding of the IgM
pentamer to surfaces of pathogens leads to activation of
the classical complement (c) cascade, as IgM, including
porcine IgM, contains a C1q binding motif [14,15]. The
results of this study showed that the cleavage site of
IdeSsuis in porcine IgM is located between the C1q-binding
motif and the antigen recognizing part. Thus, we investi-
gated whether IgM protease activity represents a novel
complement evasion mechanism protecting the pathogen
against classical complement activation.
Materials and methods
Bacterial strains and growth conditions
S. suis strain 10 is a virulent serotype 2 strain that has
previously been used for experimental infections of piglets
and for generation of isogenic mutants [16-19]. It
expresses the virulence-associated muramidase-released
protein (MRP), the extracellular factor and suilysin [20].
The capsule deficient isogenic mutant 10cpsΔEF is attenu-
ated in virulence [19] and shows increased deposition of
C3 antigen on its bacterial surface in murine serum [7].
Streptococci were grown on Columbia blood agar plates
or in BactoTM Todd Hewitt broth (THB). Escherichia (E.)
coli strains were cultured in Luria-Bertani (LB) medium. If
appropriate, antibiotics were added at the following
concentrations: ampicillin, 100 μg/mL for E. coli; chloram-
phenicol, 3.5 μg/mL for S. suis, 8 μg/mL for E. coli;
spectinomycin 100 μg/mL for S. suis.
DNA techniques and primer
Standard DNA manipulations were performed as described
[21]. Oligonucleotide primers were designed based on the
sequence of SSU0496 in the genome of S. suis P1/7 [6].
Chromosomal DNA of strain 10 served as template in allPCRs conducted for generation of inserts. DNA frag-
ments were amplified with Phusion polymerase (Promega,
Mannheim, Germany).
Generation of S. suis mutants expressing truncated
IdeSsuis
The mutant 10ΔideSsuis and its complemented strain
10ΔideSsuis pGA14ideSsuis were described previously [6]. In
frame deletion mutants expressing either the N-terminal
part homologous to IdeS (10ΔideSsuis_C-terminus) or the
large C-terminal part (10ΔideSsuis_homologue) were gener-
ated within this work using the thermosensitive plasmids
pSET5ΔideSsuis_C and pSET5ΔideSsuis_h, respectively, to
mutagenize S. suis strain 10. The following amplicons were
generated with the indicated oligonucleotide primers to
generate pSET5ΔideSsuis_C: a 619 bp ideSsuis 5′-fragment
amplified with ideSsuisdelCforPstI and ideSsuisdelCrevBamHI
and a 608 bp ideSsuis 3′-fragment generated with ideSsuis-
delCforBamHI and ideSsuisdelCrevEcoRI (Additional file 1).
Both fragments were cut with the restriction enzymes
indicated in the name of the primers and inserted into the
corresponding sites of pSET5. For the construction of
pSET5ΔideSsuis_h a 614 bp 5′-ideSsuis amplification product
was generated with the primer pair preProIdeSsuisPstI plus
postSSideSsuisBamHI and a 621 bp 3′-ideSsuis amplification
product with the primer pair IdeSsuisdelh_for_BamHI and
IdeSsuisdelh_rev_SacI (Additional file 1). Both fragments
were cut with the indicated restriction enzymes and
inserted into the corresponding sites in vector pSET5.
Restriction analysis and sequencing was performed
with pSET5ΔideSsuis_h and pSET5ΔideSsuis_C to verify
both constructs.
The allelic exchanges for generation of 10ΔideSsuis_ho-
mologue and 10ΔideSsuis_C-terminus were performed
essentially as described previously [6]. The deletion of the
genes was confirmed by PCR and Southern Blot analysis,
which included four different probes for each mutant
strain.
Generation of an unencapsulated ideSsuis mutant
In frame deletion mutagenesis of ideSsuis was conducted
in the unencapsulated S. suis strain 10cpsΔEF with the
thermosensitive plasmid pSET5ΔideSsuis constructed in our
previous study [6]. The unencapsulated double mutant
10cpsΔEFΔideSsuis was confirmed by comprehensive
Southern blot analysis using 4 different probes and two
different digestions of DNA (HincII and BamHI).
Expression and purification of recombinant proteins
The expression and the purification of the different
recombinant IdeSsuis constructs, MRP and the fibronectin-
and fibrinogen-binding protein of S. suis (FBPS) were
performed as previously described [6].
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electrophoresis (SDS-PAGE) and Western blot analysis
For αIgM Western blot analysis samples were prepared
with reducing or non-reducing sample buffer and separated
in 6% or 10% separating gels. For the detection of the Ig
light chain the samples were prepared with reducing
sample buffer and separated in a 12% separating gel.
Western blot analysis was conducted as previously
described [6] with antibodies specified together with
the final dilution in Additional file 2. Polyclonal anti-
sera were raised against IdeSsuis, IdeSsuis_homologue
and IdeSsuis_C-terminus in rabbits within our previous
study [6].
Determination of the IgM-cleavage site
The cleavage site of IdeSsuis in IgM was determined
through N-terminal sequencing after Edman degradation
of a cleavage product. For this, recombinant IdeSsuis in a
concentration of 0.07 mg/mL was incubated with
0.68 mg/mL purified porcine IgM at 37 °C for 3 h on a
rotator. The proteins were then separated under reducing
conditions in a 10% separating and 4% stacking gel. The
cleavage products were transferred to PVDF-membranes
(Merck Millipore, Schwalbach, Germany) and either
visualized in an αIgM Western blot or cut out for sequen-
cing via N-terminal Edman degradation performed on an
Applied Biosystems Procise Protein Sequencer 494C with
reagents supplied by the manufacturer (Life Technologies,
Darmstadt, Germany).
Complement hemolysis assay
A hemolysis assay was established to investigate whether
IdeSsuis activity modulates the complement-dependent
hemolysis caused by porcine Ig raised against ovine
erythrocytes. For generation of sera containing these spe-
cific antibodies (αEry sera), two piglets were immunized
with purified ovine erythrocytes and 10% Emulsigen
(MVP Laboratories Inc., Omaha, NE). Generation of
hyperimmune sera in pigs in our institute is registered
under 12A226 at the Lower Saxonian State Office for
Consumer Protection and Food Safety.
Sera were drawn from these piglets prior and post
prime as well as post booster vaccination as indicated.
Ovine erythrocytes from defibrinated blood were washed
three times with 0.9% sodium chloride solution and were
finally diluted to a 2% erythrocyte suspension. Hemolysis
experiments were conducted with 1:20 final dilutions of
porcine sera. To confirm that the hemolytic activity of
the αEry sera depended on complement activity, sera
were either inactivated by heat treatment (30 min 56 °C)
or by addition of 10 mM EDTA (30 min 25 °C). The
classical pathway was specifically inhibited by incubation
of the serum with 10 mM EGTA and 15 mM MgCl2
(30 min 25 °C).For functional analysis of IdeSsuis, 1.8 μg recombinant
protein of either IdeSsuis or a truncated derivative was in-
cubated with 100 μL of a 1:10 dilution of porcine serum
(pre immune or αEry sera) for 1.5 h on a rotator at 37 °C.
Erythrocytes were mixed with treated serum (each
100 μL) and incubated for 30 min at 37 °C on a shaker. As
control the erythrocytes were incubated in water (defined
as complete lysis of erythrocytes) or in a 0.9% sodium
chloride solution. Unlysed red blood cells were pelleted by
centrifugation (1000 × g for 5 min). One hundred μL of
the supernatant was transferred into a 96-well flat bottom
microplate and the absorbance was measured at 405 nm.
For the inhibition assay, 5.2 μg recombinant protein was
incubated with 0.4 M iodoacetamide (or as a control PBS)
for 30 min. Unbound iodoacetamide was afterwards
removed using Amicon Ultra 0.5 mL centrifugal filters
with a 10 kDa cut off (Merck Millipore, Schwalbach,
Germany). Subsequently, the iodoacetamide-inactivated
IdeSsuis contructs and its controls were investigated for
modulation of hemolysis caused by αEry sera as described
above but erythrocytes and serum were incubated for 1 h.
Detection of IgM and IgG on the surface of ovine
erythrocytes
Porcine sera drawn before and after immunization with
ovine erythrocytes (see above) were inactivated by heat
treatment (30 min 56 °C). A 2% erythrocyte suspension
generated from EDTA-blood was incubated with inacti-
vated pre and post immune serum. Inactivated serum
was pretreated with different rIdeSsuis constructs and as
control with rMRP as described above to investigate a pu-
tative modulation of IgM and IgG binding to erythrocytes.
After incubation with porcine sera, erythrocytes were cen-
trifuged, resuspended in 5% goat serum (for the detection
of IgM) or 5% rabbit serum (for the detection of IgG) and
incubated on a rotator at 8 °C for 1 h. Erythrocytes were
washed with PBS and incubated in a 1:250 dilution of a
mouse anti-porcine IgM antibody (Serotec, Puchheim,
Germany) or in a 1:10 000 dilution of a goat anti-porcine
IgG antibody (Serotec) for 1 h at 8 °C. After washing of
erythrocytes samples were incubated in a 1:500 dilution of a
phycoerythrin-labelled goat anti-mouse IgG antibody (Bio
Legend, Fell, Germany) or in a 1:1000 dilution of a Alexa
fluor 488–labelled chicken anti-goat IgG antibody (Life
Technologies, Darmstadt, Germany), respectively. Erythro-
cytes were analysed using a BD AccuriTM C6 (Becton Dick-
inson, Heidelberg, Germany) flow cytometer. For each
determination 10 000 events were acquired and analysis of
erythrocytes was carried out by dot plot analysis.
C3-deposition assay
For opsonization of S. suis with C3b/C3i, 150 μL serum
drawn after bacterin prime-vaccination or hyperimmune
serum raised against S. suis serotype 2 was added to
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of incubation at 37 °C under rotation, bacteria were centri-
fuged, washed with PBS and incubated with a polyclonal
FITC-labeled rabbit anti-human C3c antibody (Dako,
Eching, Germany) (1:150 diluted in PBS) for 1 h
at 8 °C. For opsonization of S. suis 10cpsΔEF and
10cpsΔEFΔideSsuis, 75 μL serum of colostrum-deprived
piglets (SCDP) with or without the addition of purified
porcine IgM (0.14 mg/mL) was added to 75 μL of a
culture grown to an OD600 of 0.8. Porcine IgM were
purified as described before (8). Bacteria and serum
were incubated for 30 min at 37 °C and labelled with
an antibody directed against C3 as described above.
Fluorescent bacteria were analysed after washing with
PBS and inactivation with 0.375% formaldehyde in flow
cytometry as described previously [7].
To deplete serum of complement components, serum
was pretreated with zymosan as decribed [22] with the
following modifications. A 225 μL aliquot of a zymosan
A (Sigma, Taufkirchen, Germany) stock solution (15 mg
zymosan A resuspended in 1 mL of a 14 mM sodium
chloride solution) was incubated for 30 min at 100 °C.
The suspension was centrifuged at 16 000 × g for 5 min
and the pellet was resuspended in 150 μL of porcine
serum, incubated for 30 min at 25 °C and centrifuged at
16 000 × g for 5 min. Treatment of bacteria with this
supernatant was compared to treatment of bacteria with
untreated serum to access the effect of complement
depletion by zymosan. All three complement pathways
were blocked with 10 mM EDTA (30 min 25 °C) or heat
inactivation (30 min 56 °C). To inhibit only the classical
complement pathway, sera were incubated with 10 mM
EGTA and 15 mM MgCl2 for 30 min at 25 °C. The
differently treated serum samples were incubated with
the bacteria which were subsequently analyzed for
deposition of C3 antigen as described above.
Opsonophagocytosis assay
Opsonophagocytic killing in the presence of 20% (v/v)
porcine serum was assessed essentially as described [23].
Porcine neutrophils were purified from freshly drawn
blood as outlined previously [24]. To obtain a multiplicity
of infection of 0.03, 1.5 × 105 bacteria were added to
400 μL of a neutrophil suspension in RPMI containing
5 × 106 neutrophils and 100 μL serum. The samples were
incubated for 1 h at 37 °C on a rotator. Samples incubated
with porcine αS. suis serotype 2 hyperimmune serum and
serum of colostrum-deprived piglets were included as
positive and negative control, respectively. The survival
factor as defined by the ratio of colony forming units
(CFU) at t = 60 min to the respective value at t = 0 min
was determined for each strain. The ratio of the survival
factors of 10ΔideSsuis and wt was calculated to assess
attenuation of the 10ΔideSsuis mutant.Bactericidal assay
Survival of S. suis in porcine blood was determined as
described in a previous study [6]. Briefly, 500 μL of
heparinized blood (16 I. U. heparin/mL) were infected
with 1.5 × 105 CFU using stocks of frozen bacteria with
15% glycerol after thawing. The blood was incubated for
2 h at 37 °C on a rotator. Bactericidal assays were
conducted with blood drawn from 5 to 7 week old piglets
6 to 14 days after prime vaccination with a S. suis serotype
2 bacterin. These piglets were not included in the
experimental infection experiment.
Animal experiment
German Landrace piglets (n = 25) free of sly +mrp + epf +
cps2+ strains were infected experimentally either with
strain 10 (n = 9) or strain 10ΔideSsuis (n = 8) or
10ΔideSsuis_homologue (n = 8). Piglets were cared for
in accordance with the principles outlined in the
European Convention for the Protection of Vertebrate
Animals Used for Experimental and Other Scientific
Purposes [25]. The animal experiment of this study
was approved by the Committee on Animal Experiments
of the Lower Saxonian State Office for Consumer
Protection and Food Safety (permit no. 33.9-42502-
04-12/0965).
All piglets were prime-vaccinated at an age of 5–6
weeks with a bacterin generated with S. suis strain 10
grown overnight and inactivated in 0.2% formaldehyde.
Emulsigen was added as adjuvant (20% [vol/vol]). Each
immunization dose contained approximately 109 bacteria.
At an age of 7 to 8 weeks piglets were challenged
12 days after prime vaccination. Piglets were intrana-
sally infected after predisposition through intranasal
treatment with 1% acetic acid as described previously
[16]. Criteria for morbidity were fever (≥40.2 °C) or
specific clinical signs such as convulsions or severe
lameness. In the case of high fever (≥40.5 °C), apathy
and anorexia persisting over 36 h as well as in all
cases of clinical signs of acute polyarthritis or severe
meningitis animals were euthanized for reasons of
animal welfare. All surviving piglets were sacrificed
15 days post infection (dpi).
After euthanasia every animal went through the same
procedure of necropsy including predefined collection of
samples for histological and bacteriological investiga-
tions. Fibrinous-suppurative inflammations were scored
in blinded experiments as described previously [16]. To
allow comparison of groups the sum of the highest
scores of each animal for any of the investigated organs
was divided by the number of animals (ω = Σscoremax/
nanimals). Isolation of the challenge strains was confirmed
in a PCR for detection of epf and cps2 [26] and in
ideSsuis-specific PCRs using oligonucleotide primers
specified in Additional file 1.
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antibodies
MRP, used as antigen for the IgG ELISA, is a dominant
immunogen of this S. suis pathotype [17,23,27]. The
detection of IgG titers against MRP was performed as
described [16]. For the measurement of αS. suis IgM or
IgG antibody titers Maxisorb® plates (Nunc, Rochester, NY)
were coated with 1 × 107 inactivated S. suis wt bacteria/well.
Every sample and the controls were measured in a
duplicate series of four (reference serum: seven) twofold
dilutions in PBST starting with a dilution of 1:50. For
the detection of S. suis specific IgM antibodies the
plates were incubated with a dilution of 1:10 000 of a
POD-conjugated goat anti-porcine IgM antibody (Thermo
Scientific, Schwerte, Germany, catalog number PA1-84625)
for 1 h at 37 °C. Blocking, washing and development of
ELISA plates as well as calculation of ELISA units
was conducted as previously described [17]. Data were
only considered if they met the following criteria: a devi-
ation of duplicates of no more than 22%, a slope of the
linear portion of the reference standard curve between 0.8
and 1.2, a correlation coefficient between 0.9 and 1.0, and
controls within established ranges.
Statistical analysis
Experiments were performed at least three times and if not
stated otherwise one-way analysis of variance (ANOVA)
using Dunnetts adjustment or Tukeys multiple comparison
test was used. ELISA-values were compared using
the Mann–Whitney U-Test. Statistical analysis of
Kaplan-Meier diagrams was conducted with the log-rank
test. Means and standard deviation of the results are
shown. Probabilities lower than 0.05 were considered
significant (p < 0.05 *, p < 0.01 ** and p < 0.001 ***).
Results
IdeSsuis cleaves the heavy chain of IgM at the N-terminus
of the C3 domain
Cleavage of IgM by IdeSsuis was previously identified
and characterized in Western blot analysis under
non-reducing conditions [6]. In this study we used a
different αIgM antibody recognizing only the reduced
heavy chain of IgM to detect IgM cleavage products
after IdeSsuis incubation (Figure 1). This allowed us to
successfully determine the N-terminal sequence of the
32 kDa cleavage product as SPITVFAIAP via Edman
sequencing (Figure 1). Based on the N-terminal sequence,
IdeSsuis cleaves the heavy chain of IgM at the N-terminus
of the C3 domain. In accordance with this result, reducing
αIgM Western blot analysis revealed two cleavage
products of 41 kDa and 32 kDa, which putatively
included V1-C1-C2 and C3-C4 domains of the heavy
IgM chain, respectively (Noteworthy, this αIgM antibody
does not recognize the light chain of IgM).Cysteines involved in disulphide bonds are con-
served between human and porcine IgM. Assuming
that constitution of disulfide bonds is also conserved
between the two species, the cysteines of C1 and C2 do-
mains of porcine IgM should form intradomain and inter-
chain disulphide bonds but not link monomers to the
multimer. The Western blot in Figure 1 and further ana-
lysis with antibodies recognizing unreduced IgM [6] and
the light chain of IgM only (Figure 1A), suggested that
IgM is cleaved by IdeSsuis only at the indicated site. IgM
bound to the bacterial surface is also cleaved by IdeSsuis
and results in release of Fcμ cleavage products [6], which
most likely include the C3 and C4 domain of the heavy
chain of porcine IgM. This cleavage pattern is likely
to affect IgM effector functions, in particular reduced
activation of the classical complement pathway, as the
C3 domain includes the C1q binding motif of porcine
IgM [28,29].
IdeSsuis abrogates activation of the classical complement
pathway
The classical complement activation pathway can be stud-
ied in hemolysis assays using sera containing antibodies
directed against erythrocytes. We investigated the impact
of IdeSsuis on complement activation in a hemolysis assay
including sera drawn from piglets vaccinated with
erythrocytes (αEry sera). In accordance with complement
activation, treatment of αEry sera with heat, EDTA or
EGTA plus MgCl2 completely abolished the hemolytic
activity of the αEry sera (Figure 2A). For functional
analysis of IdeSsuis, αEry sera drawn after prime and
booster vaccination were treated with different rIdeSsuis
constructs (Figure 2B) prior incubation with erythrocytes.
Incubation of the post-prime αEry serum with rIdeSsuis
and rIdeSsuis_homologue (the domain containing the IgM
protease), almost completely abolished this hemolysis
(Figure 2C). Noteworthy, treatment of the post-prime
αEry serum with two recombinant control proteins (MRP
and FBPS), did not result in abrogation of hemolysis
(Figure 2C). Interestingly, treatment of αEry sera with
proteolytic inactive construct rIdeSsuis_C_terminus led
also to a significant reduction of hemolysis indicating a
separate role of the C-terminus in complement evasion.
However, significant differences between inhibition of
complement activation through αEry sera drawn after
prime and booster vaccination were only observed for the
IdeSsuis constructs with IgM protease activity (Figure 2C).
The different recombinant IdeSsuis constructs were
treated with the protease inhibitor iodoacetamide prior to
incubation with αEry serum to assess the impact of pro-
teolytic activity on complement inhibition. Preincubation
of rIdeSsuis and rIdeSsuis_homologue with iodoacetamide
completely abrogated the complement inhibiting activity
of these proteins (Figure 2D).
Figure 1 IdeSsuis cleaves the heavy chain of porcine IgM. (A) αIg light chain and αIgM Western blot analysis of purified porcine IgM after
incubation +/− rIdeSsuis. Samples were separated in an SDS-gel under reducing conditions. The marker bands are shown on the left side
(sizes in kDa). (B) The IgM-cleavage product highlighted in red was characterized by N-terminal Edman-sequencing. The identified sequence is
shown in red and corresponds to the constant domain 3 of the IgM heavy chain. The putative C1q binding motif is marked in blue. Domains C2 and
C4 are underlined. The obtained sequence was taken directly from the NCBI database. (C) Illustration of an IgM-monomer with the indicated cleavage
site and the location of the putative C1q-binding motif.
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with erythrocytes after incubation with inactivated post
prime and post booster αEry sera to differentiate binding
of specific IgM and IgG in these sera. Both sera contained
erythrocyte-specific IgG and IgM in contrast to the pre
immune serum. Incubation with the post prime serum
led to significantly higher percentage of IgM-labelled
erythrocytes and respective mean fluorescence intensity
(MFI) in comparison to the post booster serum. Vice
versa, IgG staining on erythrocytes resulted in a much
higher MFI after incubation in post booster serum
(Figures 3A and B). We investigated modulation of
IgM and IgG antigen binding to erythrocytes by treatment
of the post prime αEry serum with the different recombin-
ant IdeSsuis constructs. Treatment of this serum with
proteolytic active rIdeSsuis and rIdeSsuis_homologue led
to a significant reduction of the percentage of erythrocytes
labelled with IgM and the respective MFI (Figures 3C
and D) in contrast to the treatment with the non-
proteolytic constructs. Binding of IgG to the erythrocytes
was not modulated by incubation of the αEry serum with
any of the recombinant IdeSsuis constructs.In conclusion, IdeSsuis interferes with the classical com-
plement activation pathway. The results of the hemolysis
assay suggest that IdeSsuis interferes with complement
activation by two mechanisms, firstly, by its IgM protease
activity and, secondly, by some yet unknown function of
the large non-proteolytic C-terminal domain.
Expression of IdeSsuis reduces IgM-triggered complement
deposition on the bacterial surface of an unencapsulated
mutant
We investigated deposition of C3 on the surface of
opsonized S. suis strains by flow cytometry to further
investigate the hypothesis that IdeSsuis is involved in
complement evasion. After opsonization of S. suis wt and
10ΔideSsuis with different porcine sera with moderate to
high specific IgM titers the percentage of bacteria with
stained C3 antigen (most likely C3b/C3i) was slightly
increased in the mutant 10ΔideSsuis (Additional file 3).
Specifically, 39.2% of wt (SD = 11.0%) and 42.8% of
10ΔideSsuis (SD = 10.2%) bacteria were C3-labelled
after opsonization in sera of bacterin-primed piglets
(Additional file 3). The sera of these bacterin-primed
Figure 2 Hemolysis caused by the classical complement activation pathway is abrogated by IdeSsuis in dependence of the protease
activity. (A) Purified sheep erythrocytes were incubated with water (defined as 100% hemolysis), physiological sodium chloride solution (NaCl),
sera of a piglet drawn before (pre vaccination serum) and 7 days after prime vaccination (post vaccination αEry serum) with ovine erythrocytes.
The αEry serum was heat inactivated or treated with EDTA to access the impact of complement activation. To specifically inhibit the classical
complement pathway 10 mM EGTA plus 15 mM MgCl2 was used. (B) Illustration of rIdeSsuis and its truncated derivatives. The amino acids of
IdeSsuis included in these constructs are superscribed. The region homologous to IdeS is shaded. (C) Complement dependent hemolysis is
reduced by pretreatment of the indicated different αEry sera with rIdeSsuis, rIdeSsuis_homologue (rIdeSsuis_h) and rIdeSsuis_C_terminus (rIdeSsuis_C)
but not with rMRP and rFBPS. (D) Proteolytic activity of rIdeSsuis and rIdeSsuis_homologue is crucial for complement inhibition. The IdeSsuis constructs
were incubated with the cysteine-protease inhibitor iodoacetamide prior to incubation with the αEry sera as indicated. The final dilutions of porcine
sera in the hemolysis assay were 1:20 in all cases. Bars and error bars represent mean values and standard deviations, respectively. Significant
differences are indicated (* p < 0.05; ** p < 0.01; *** p < 0.001).
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(34 – 103 ELISA units) and αS. suis IgG (69 – 161
ELISA units) but low αMRP titers (below 15 ELISA units).
After addition of EGTA and MgCl2 to these sera only 7.1%
(SD = 4.8%) and 7.7% (SD = 6.8%) of wt and 10ΔideSsuis
bacteria, respectively, were labelled with the αC3 antibody
indicating that complement is mainly activated by the
classical activation pathway during early adaptive immune
responses (Additional file 3).
We hypothesized that activation of the classical
complement pathway in this assay was determined by
specific IgM and IgG and that redundant complement
evasion mechanisms in S. suis serotype 2 might limit
detection of phenotypic differences between wt and
10ΔideSsuis. Thus, we deleted ideSsuis in an unencapsulated
isogenic strain (10cpsΔEFΔideSsuis) to avoid complementinhibition through the sialylated capsule of S. suis serotype
2. Furthermore, effects of specific IgG were excluded
using serum from colostrum-deprived piglets (SCDP). As
shown in Figure 4A approximately 10% of either
10cpsΔEF or 10cpsΔEFΔideSsuis bacteria were stained with
C3 after opsonization with SCDP. Importantly, the
percentages of C3-stained 10cpsΔEF increased to
about 20% after addition of purified porcine IgM to
SCDP prior to opsonization, but fourfold (to 40%) for
10cpsΔEFΔideSsuis bacteria lacking IgM protease activity
(Figure 4). Differences in C3 deposition between 10cpsΔEF
and 10cpsΔEFΔideSsuis were highly significant for the per-
centage of labelled bacteria and the MFI (Figure 4).
Addition of the classical complement pathway inhibitor
(EGTA plus MgCl2) reduced the percentage of C3 labelled
bacteria to 4.7% (10cpsΔEF) and 4.9% (10cpsΔEFΔideSsuis)
Figure 3 The proteolytic rIdeSsuis constructs modulate IgM binding to the surface of erythrocytes after incubation in αEry sera. (A, B)
Flow cytometry analysis of IgM and IgG binding to ovine erythrocytes after incubation with porcine sera drawn pre, post prime or post booster
vaccination with ovine erythrocytes (generation of αEry sera). (C, D) Binding of specific IgM antigen to the surface of ovine erythrocytes is
significantly reduced after pretreatment of a post prime αEry serum with rIdeSsuis and rIdeSsuis_homologue. The post prime αEry serum was
preincubated with the indicated IdeSsuis constructs and as a control with MRP. (A, C) The percentage of erythrocytes labelled with IgM or IgG and
(B, D) the mean fluorescence intensities are shown. αEry sera were inactivated in these assays to allow flow cytometric analysis of erythrocytes.
Bars and error bars represent mean values and standard deviations, respectively. Significant differences are indicated (***p < 0.001) except for
differences between pre and post vaccination sera.
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results confirm that C3 deposition on the surface of
S. suis might be determined by IgM-mediated activa-
tion of the classical complement pathway and show
that S. suis reduces this IgM-mediated C3 deposition
by expression of IdeSsuis.
The mutant 10ΔideSsuis is attenuated in survival in
opsonophagocytosis assays in the presence of specific IgM
As rIdeSsuis interfered with complement activation using
sera with specific antibodies, we hypothesized that
expression of the IgM protease IdeSsuis contributes to
survival in opsonophagocytosis assays including a
porcine serum with specific IgM and comparatively low
specific IgG titers (αS. suis IgM: 29.2 ELISA-units and for
comparison: αMRP IgG: 12.8 ELISA-units). Phenotypic
analysis of S. suis was conducted in this study using the
mutant 10ΔideSsuis [6] and two new in frame deletionmutants expressing truncated IdeSsuis constructs. These
new mutants, designated 10ΔideSsuis_C-terminus and
10ΔideSsuis_homologue, expressed the N-terminal part
homologous to IdeS and the large C-terminal part lacking
homologies, respectively (Additional file 4). Noteworthy,
10ΔideSsuis _C-terminus released IgM protease activity
in the supernatant in contrast to 10ΔideSsuis and
10ΔideSsuis_homologue (Additional file 4). As shown
in Figure 5A 10ΔideSsuis and 10ΔideSsuis_homologue
had a significant lower survival factor compared to the wt
strain and the survival factor for 10ΔideSsuis_C-terminus
was also found to be lower compared to the wt strain. The
extent of attenuation of 10ΔideSsuis was significantly lower
in opsonophagocytosis assays including serum from a
colostrum-deprived piglet in comparison to assays
including specific IgM. Inhibition of complement reduced
the attenuation of the mutant 10ΔideSsuis significantly
(Figure 5B).
Figure 4 Expression of IdeSsuis reduces C3 deposition on the
surface of an unencapsulated mutant triggered by IgM-mediated
activation of the classical complement pathway. C3 antigen bound
to the surface of the unencapsulated mutant 10cpsΔEF and the
double mutant 10cpsΔEFΔideSsuis was detected through flow
cytometry analysis. Bacteria were opsonized with sera from
colostrum-deprived piglets (SCDP) or SCDP spiked with purified
porcine IgM (SCDP plus IgM). To inactivate the classical complement
activation pathway SCDP plus IgM was pretreated with EGTA MgCl2.
As control non-opsonized bacteria (incubated in PBS) were incubated
with the C3 specific antibody. (A) The percentage of bacteria with
antibody-labelled C3 and (B) the mean fluorescence intensity of the
samples are shown. Bars and error bars represent mean values and
standard deviations, respectively. Significant differences are indicated
(*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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piglets suggests attenuation of the mutant 10ΔideSsuis
Based on the in vitro results we considered IdeSsuis to be
a putative virulence factor of S. suis in piglets with high
titers of specific IgM. Thus, we conducted experimental
infection of piglets prime vaccinated with a bacterin.
Immunological screening of these piglets confirmed
that these piglets had high specific IgM titers and low
IgG titers against MRP, a main immunogen of this
invasive S. suis pathotype (Additional file 5). We infected
piglets with the wt and the 10ΔideSsuis mutant as well as
with the partial mutant 10ΔideSsuis_homologue, which
expressed only the C-terminus and showed no IgM
proteolysis (Additional file 4). The complemented mutant
was not included in the experimental infection because it
showed attenuation in growth in medium (unpublished
results). Sixty three percent of the piglets infected with the
mutant 10ΔideSsuis survived this experiment, whereas only
33% did so in the wt infected group (p = 0.125) (Figure 6A).
Furthermore, 50% and 11% of 10ΔideSsuis and wt infected
piglets, respectively, were free of clinical signs throughout
the observation period (p = 0.076; Figure 6B). Furthermore,
10ΔideSsuis infected piglets had a lower pathohistological
score (ω = 2.2) in comparison to wt infected animals
(ω = 3.7; Table 1). In general, detection of fibrinosuppura-
tive lesions was associated with detection of the infection
strain. The mutant 10ΔideSsuis was not detectable in
any inner organ in 5 of 8 infected piglets (Table 2).
However, the group infected with the deletion mutant
10ΔideSsuis_homologue showed mortality and morbidity
as well as a high rate of infection of inner organs very
similar to the wt infected group (Figure 6; Table 2).
In summary, the results of the experimental infection sug-
gested an attenuation of the mutant 10ΔideSsuis in prime-
vaccinated growing piglets with high titers of specific IgM.
IdeSsuis positively affects survival of S. suis in blood of
piglets with high specific IgM titers ex vivo
As bacteremia is considered to be a critical step in the
pathogenesis of invasive S. suis diseases, we further
investigated survival of the different ideSsuis mutants
and the wt in porcine blood with high IgM titers
ex vivo. Thus, we evaluated IdeSsuis-dependent survival in
blood from bacterin prime-vaccinated piglets. These
piglets had significantly higher IgM titers against S. suis
than unvaccinated weaning piglets investigated for com-
parison (p < 0.01; Additional file 6). As shown in Figure 7,
the two mutants deficient in IgM proteolysis (10ΔideSsuis
and 10ΔideSsuis_homologue) are significantly attenuated in
survival in blood drawn from piglets prime-vaccinated
with a bacterin. In contrast, the mutant expressing the
truncated N-terminal domain with IgM protease activity
(10ΔideSsuis_C-terminus) was not attenuated in growth in
porcine blood ex vivo.In conclusion, expression of the IgM protease IdeSsuis
promotes increased survival of S. suis in porcine blood
ex vivo, at least in the presence of specific IgM.
Discussion
The IgM pentamer is a very important activator of the
classical complement pathway. It has been estimated
Figure 6 Mortality (A) and morbidity (B) of prime-vaccinated
growing piglets intranasally challenged with the indicated S.
suis strains. Growing piglets were infected with wild type strain
10 (wt), 10ΔideSsuis (Δ) and 10ΔideSsuis _homologue (Δ_h) 12 days
after prime vaccination with a homologous S. suis serotype 2 bacterin.
A piglet was determined as morbid in the case of elevated body
temperature (≥40.2 °C) or specific clinical signs (signs of central
nervous dysfunction or severe lameness). Statistical analysis of the
Kaplan-Meier diagrams was conducted with the log-rank test
(all p-values are shown below the diagrams).
Figure 5 IdeSsuis promotes survival in opsonophagocytosis assays
including purified porcine neutrophilic granulocytes and serum
with specific IgM titers. (A) Survival of strain 10 (wt), 10ΔideSsuis
(Δ), 10ΔideSsuis_homologue (Δ_h) and 10ΔideSsuis_C-terminus (Δ_C) in
opsonophagocytosis assays with serum from a piglet with specific IgM.
(B) Attenuation of 10ΔideSsuis in opsonophagocytosis assays depends
on active complement and adaptive immunity. The ratios of the
survival factors of 10ΔideSsuis to the respective survival factors of wt are
shown. A ratio of 1 is depicted by the horizontal line and refers to a
lack of attenuation. To access the impact of complement, the post
immune serum with specific IgM used for experiments shown in
(A) was heat-inactivated or treated with zymosan. Samples with
active and heat-inactivated serum from a colostrum-deprived pig were
included to investigate whether this IdeSsuis-mediated phenotype
depends on adaptive immunity. Bars and error bars represent mean
values and standard deviations, respectively. Significant differences
between strains and ratios of survival factors in (A) and (B), respectively,
are indicated (* p< 0.05, ** p < 0.01).
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activate complement is equivalent to the respective effi-
ciency of 1000 IgG molecules [29]. As cleavage of IgM
by IdeSsuis occurs at a site located between the antigen-
recognizing part and the Fc-part containing the putativeC1q binding motif, it was reasonable to hypothesize
that IgM cleavage by IdeSsuis is an important comple-
ment evasion mechanism of S. suis. In this study we
obtained in vitro data supporting the hypothesis that
IdeSsuis is involved in complement evasion: (i) different
recombinant IdeSsuis constructs abolished the hemolysis
induced by activation of the classical complement
pathway in serum with specific IgM directed against
erythrocytes; (ii) attenuation of the mutant 10ΔideSsuis in
opsonophagocytosis assays was complement-dependent;
(iii) IgM-triggered deposition of C3 on the bacterial
surface is reduced by IdeSsuis expression and (iv)
attenuation of 10ΔideSsuis in survival in porcine blood
ex vivo was observed in blood from piglets with high
specific IgM titers.
Table 1 Scoring of fibrinosuppurative lesions of growing piglets intranasally infected with the indicated S. suis strains






in three or more
locations










5c 3d 1e 4c 2d 1e 4c 2d 1e 4c 2d 1e 4c 2d 1e 4c 2d 1e ωf
wt 1/9 5/9 1/9 0/9 0/9 4/9 0/9 0/9 2/9 0/9 0/9 3/9 3/9 0/9 6/9 0/9 0/9 0/9 0/9 0/9 3.7
Δ 3/8 3/8 3/8 0/8 0/8 0/8 1/8 0/8 1/8 2/8 0/8 1/8 1/8 3/8 1/8 2/8 0/8 0/8 0/8 0/8 2.2
Δ_h 2/8 4/8 2/8 0/8 0/8 3/8 0/8 0/8 0/8 0/8 0/8 0/8 4/8 2/8 3/8 1/8 0/8 2/8 0/8 0/8 2.9
aInfection strains were strain 10 (wt), 10ΔideSsuis (Δ) and 10ΔideSsuis _homologue (Δ_h).
bNeutrophilic accumulation of the splenic red pulp.
cScoring of 4 and 5 indicates moderate to severe diffuse or multifocal fibrinosuppurative inflammations.
dScoring of 2 and 3 indicates mild focal fibrinosuppurative inflammation.
eIndividual single perivascular neutrophils received a score of 1.
fω = Σscoremax/nanimals [15].
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interferes substantially with activation of the classical
complement pathway. Importantly, IdeSsuis mediated
inhibition of complement activation by erythrocyte
specific IgM was abrogated by pretreatment of IdeSsuis
and IdeSsuis_homologue with the protease inhibitor
iodoacetamide. As IgM is the only known substrate of
this protease [6] and inhibition of IgM proteolysis by
iodoacetamide was confirmed in this assay, we con-
clude that IgM proteolysis is involved in interference
of IdeSsuis with complement activation. Accordingly,
C3 deposition on 10cpsΔEFΔideSsuis bacteria in serum
from colostrum-deprived piglets spiked with specific
IgM is significantly higher compared to C3 deposition
on the IdeSsuis expressing strain 10cpsΔEF.
Though IgM is much more powerful in activation of
the classical complement pathway than IgG, immune
evasion mechanism of bacteria counteracting the
classical complement pathway have so far only been
described for factors interacting with IgG. Specifically,
protein H expressed by group A streptococci (GAS)
reduces C3 deposition on IgG-coated beads and inhibits




Number of pigs with an
isolate of the infection
strain in at least one
inner organb
Number of pigs with indicated
Tonsils Lungc Serosad
wt 6/9 5/9 5/9 5/9
Δ 3/8 2/8 1/8 0/8
Δ_h 7/8 3/8 6/8 5/8
aInfection strains were strain 10 (wt), 10ΔideSsuis (Δ) and 10ΔideSsuis _homologue (Δ_
and methods.
bPiglets with isolates of the challenge strain exclusively from the tonsil were not co
cOne cranial lobe was investigated.
dPleural, peritoneal or pericardial cavity.
eCerebrospinal fluid.
fPunctures of both tarsal and carpal joints were investigated in each animal. In caseFurthermore, protection against opsonophagocytic killing
of GAS in the presence of specific IgG is mediated by M-
proteins and M-like proteins acting as Fc-receptors [31]
and by the IgG protease IdeS [32]. In light of the different
virulence factors counteracting IgG-mediated activa-
tion of the classical complement pathway, it is very
much surprising that a bacterial evasion mechanism
counteracting IgM-mediated complement activation has
to the best of our knowledge not been described. The
interference of IdeSsuis with IgM-mediated complement
activation is important for pathogenesis, since survival of
S. suis in porcine blood of prime-vaccinated piglets is
significantly increased by IdeSsuis expression and clinical as
well as pathological findings after experimental infection
of respective piglets suggested attenuation of the isogenic
mutant 10ΔideSsuis.
Deposition of C3b on the surface of the encapsulated
S. suis serotype 2 strains was only slightly determined by
IdeSsuis expression under the chosen experimental condi-
tions. The percentage of bacteria with detectable C3b
deposition was below 16% after incubation of S. suis strains
10 and 10ΔideSsuis in serum of colostrum-deprived piglets
supplemented with purified porcine IgM (results notith a bacterin and then infected with the indicated
site of infection straina isolation/total number of pigs
Spleen Liver Brain, CSFe Joint fluidf Endocard
5/9 6/9 1/9 3/9 3/9
3/8 2/8 3/8 1/8 1/8
6/8 5/8 3/8 5/8 6/8
h). Identification was conducted through PCR as described in Materials
nsidered.
s of lameness additional joint punctures of the respective limb were screened.
Figure 7 The mutants 10ΔideSsuis (Δ) and 10ΔideSsuis
_homologue (Δ_h) are attenuated in survival in porcine blood
ex vivo. The blood was drawn from 7 different growing piglets with
an age of 5–7 weeks 6–14 days after prime vaccination with a S. suis
bacterin. The mutant 10ΔideSsuis _C-terminus (Δ_C) not deficient in
IgM proteolysis was also included. The bars and error bars represent
mean values and standard deviations, respectively. Significant
differences are indicated (** p < 0.01; *** p < 0.001).
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lated mutants (Figure 4). This indicates in accordance
with published results [7] that the capsule of serotype
2 is a main inhibitor of C3b deposition. Thus, we
speculate that IdeSsuis expression might be crucial for
bacterial survival (i) during reduced capsule expression,
(ii) in the presence of very high IgM titers against the
polysaccharide capsule and (iii) in strains of serotypes that
lack capsular sialic acid [8].
Two factor H binding proteins, have recently been
identified in S. suis [12,13]. Factor H bound to the
surface of S. suis serves as a cofactor for the factor-I
mediated cleavage of C3b [12]. Deletion of the gene
fhb encoding one of the factor H binding proteins
led to a significant increase in C3b/iC3b deposition
after opsonization with human serum. Activation of
human complement was elicited by S. suis mainly via
the alternative pathway under the chosen experimen-
tal conditions. However, in this work we demonstrate
that in growing piglets with high titers of specific
IgM the percentage of bacteria with antibody-labelled
C3 is mainly determined by the classical pathway.
This is important, because piglets with early adaptive
immune responses are often affected by S. suis diseases
and development of vaccines eliciting protection during
this early immune response stage would substantially
improve animal health.
Cleavage of IgM might have important biological con-
sequences in addition to prevention of C3b deposition
on the bacterial surface. Based on the identified cleavage
site in the IgM heavy chain, IdeSsuis activity should leadto release of a pentameric Fc-molecule including only
C3 and C4 domains of the heavy IgM chains. We speculate
that the cleavage product detected above the 250 kDa
marker lane in Western blot analysis under non-reducing
conditions [6] constitutes this pentameric molecule.
Future studies should consider whether this putative
C3-C4-pentamer modulates functions of the immune
system. It is known that ½Fc IgG fragments released
upon cleavage of IgG by IdeS prime neutrophils to
respond to a second stimulus with an enhanced rate
of reactive oxygen species production [33]. This might
lead to activation of immune cells at sites remote from the
pathogen. Similarly, the putative C3-C4 pentamer might
also activate immune cells, e.g. by binding to the Fcμ
receptor [34].
The results of the experimental infection suggested
attenuation of the mutant 10ΔideSsuis. However, the
mutant expressing only the C-terminus of IdeSsuis
(10ΔideSsuis_homologue) caused morbidity in prime-
vaccinated piglets comparable to the wt and unlike the
mutant 10ΔideSsuis, which suggests that IgM proteolysis as
such was not crucial for the outcome of the animal experi-
ment and that the C-terminus of IdeSsuis carries out im-
portant, yet unknown functions. Accordingly, the
recombinant truncated protein consisting only of the C-
terminus of IdeSsuis showed also a significant interference
with complement activation in the hemolysis assay suggest-
ing an additional function of IdeSsuis in complement inhib-
ition but IgM proteolysis. Interestingly, the interference of
this non-proteolytic construct did not seem to depend on
the ratio of erythrocyte-specific IgM and IgG titers, in con-
trast to the interference by the IgM protease domain (as es-
timated by comparative analysis of post prime and post
booster αEry sera). Further studies are certainly needed to
decipher further functions of IdeSsuis in complement eva-
sion and their role in host-pathogen interaction.
Host-pathogen interaction of S. suis was investigated
during early adaptive immune responses in this study.
Survival in porcine blood with high specific IgM titers is
significantly determined by expression of the IgM protease
IdeSsuis. Accordingly, the in vitro results of this study
demonstrate that IdeSsuis abrogates activation of the
classical complement system. As IdeSsuis is expressed
by all investigated S. suis strains [6], this unique virulence
mechanism appears to be crucial for the evolutionary
success of this pathogen.Additional files
Additional file 1: Sequences of oligonucleotide primers. Name,
sequence and position of target sequence of primers used in this study.
Additional file 2: Antibodies used in Western blot analysis.
Specificity, source, conjugation and used dilution of antibodies.
Seele et al. Veterinary Research  (2015) 46:45 Page 13 of 14Additional file 3: Flow cytometry analysis of C3 antigen (C3b/C3i)
bound to opsonized S. suis strain 10 (wt) and 10ΔideSsuis (Δ). Mean
values and standard deviations (S. D.) for the percentage of C3-labelled
bacteria and respective mean fluorescence intensity after opsonization of
bacteria with sera including specific immunoglobulins as indicated.
Additional file 4: 10ΔideSsuis_homologue (Δ_h) and 10ΔideSsuis_
C-terminus (Δ_C) release stabile fragments of IdeSsuis into the
supernatant in accordance with IgM cleavage activity in the case
of Δ_C. (A) αIdeSsuis_C-terminus and αIdeSsuis_homologue Western blot
analysis of culture supernatants of 10ΔideSsuis _homologue (Δ_h),
10ΔideSsuis_C-terminus (Δ_C), 10ΔideSsuis (Δ) and wild type strain 10 (wt).
(B) 10ΔideSsuis_C-terminus but not 10ΔideSsuis_homologue exhibits
IgM-cleaving activity. αIgM Western blot analysis of diluted porcine
serum incubated with concentrated culture supernatants of
10ΔideSsuis_homologue (Δ _h), 10ΔideSsuis _C-terminus (Δ_C),
10ΔideSsuis (Δ) and wild type strain 10 (wt) or with PBS.
Additional file 5: Immunological analysis of piglets used in the
experimental infection (see Figure 6). (A) α-S. suis serotype 2 (ST2)
IgM, (B) α-ST2 IgG titers and (C) α-MRP IgG titers were determined in
serum samples of piglets after prime vaccination with a S. suis ST2
bacterin (before experimental infection) and as a control in unvaccinated
piglets. Significant differences are indicated. Mean values are shown by
horizontal lines.
Additional file 6: Immunological analysis of piglets used for the
bactericidal assay (see Figure 7). (A) α-S. suis serotype 2 (ST2) IgM and
(B) α-MRP IgG titers were determined in serum samples of these 7
growing piglets (prime-vaccinated) and for comparison in unvaccinated
piglets. Prime vaccination was conducted with a S. suis serotype 2 bacterin.
Significant differences are indicated (** p < 0.01). Horizontal lines represent
mean values.
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